STOCK TITAN

AbbVie to Present at Citi's 2024 Global Healthcare Conference

AbbVie (NYSE: ABBV) has announced its participation in Citi's 2024 Global Healthcare Conference scheduled for Tuesday, December 3, 2024.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

AbbVie (NYSE: ABBV) has announced its participation in Citi's 2024 Global Healthcare Conference scheduled for Tuesday, December 3, 2024. The company will be represented by three executive leaders: Scott T. Reents (CFO), Jeffrey R. Stewart (CCO), and Dr. Roopal Thakkar (EVP of R&D and CSO), who will present at 9:15 a.m. Central time.

The presentation will be accessible via live audio webcast through AbbVie's Investor Relations website, with an archived version available later that day.

Loading...
Loading translation...
Argus Session date unavailable
+0.06% session move Open Argus
Details

News Market Reaction – ABBV

The recorded move for ABBV in the trading session of this news was +0.06%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NORTH CHICAGO, Ill., Nov. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024. Scott T. Reents, executive vice president, chief financial officer, Jeffrey R. Stewart, executive vice president, chief commercial officer and Roopal Thakkar, M.D., executive vice president, Research & Development and chief scientific officer, will present at 9:15 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube. 

AbbVie logo

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-citis-2024-global-healthcare-conference-302314669.html

SOURCE AbbVie

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is AbbVie (ABBV) presenting at Citi's 2024 Global Healthcare Conference?

AbbVie (ABBV) is presenting at Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024, at 9:15 a.m. Central time.

Who are the AbbVie executives presenting at Citi's 2024 Healthcare Conference?

Scott T. Reents (CFO), Jeffrey R. Stewart (CCO), and Dr. Roopal Thakkar (EVP of R&D and CSO) will be presenting at the conference.

How can investors watch AbbVie's (ABBV) presentation at Citi's 2024 Healthcare Conference?

Investors can watch the presentation through a live audio webcast on AbbVie's Investor Relations website at investors.abbvie.com. An archived version will be available later the same day.

Keep reading